NDA & Supplemental Drug Application Regulations in Pharma

This training program on the regulatory framework for new and supplemental drug applications is designed for Regulatory Affairs professionals in the Pharma and Life Sciences sector. It addresses the challenge of approval delays and regulatory questions arising from gaps in application strategy, content alignment, and submission quality. Participants will gain the ability to plan, prepare, and manage compliant new and supplemental drug applications across their life cycle. The program uses real submission scenarios and health authority review examples to ensure practical application.